AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife System
ANGO Stock | USD 12.04 0.02 0.17% |
About 59% of all AngioDynamics' investors are looking to take a long position. The analysis of overall sentiment of trading AngioDynamics stock suggests that some investors are interested at this time. AngioDynamics' investing sentiment overview a quick insight into current market opportunities from investing in AngioDynamics. Many technical investors use AngioDynamics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
AngioDynamics |
AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vasc
Read at businesswire.com
AngioDynamics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards AngioDynamics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
AngioDynamics Maximum Pain Price Across April 17th 2025 Option Contracts
AngioDynamics' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of AngioDynamics close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of AngioDynamics' options.
AngioDynamics Fundamental Analysis
We analyze AngioDynamics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AngioDynamics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AngioDynamics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
AngioDynamics is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
AngioDynamics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AngioDynamics stock to make a market-neutral strategy. Peer analysis of AngioDynamics could also be used in its relative valuation, which is a method of valuing AngioDynamics by comparing valuation metrics with similar companies.
Peers
AngioDynamics Related Equities
ATRC | AtriCure | 0.63 | ||||
NVST | Envista Holdings | 0.33 | ||||
MMSI | Merit Medical | 0.32 | ||||
ATR | AptarGroup | 0.59 | ||||
COO | Cooper Companies, | 0.67 | ||||
KRMD | Repro Med | 1.21 | ||||
ICUI | ICU Medical | 1.44 | ||||
HAE | Haemonetics | 2.51 | ||||
AKYA | Akoya Biosciences | 3.74 |
Check out AngioDynamics Hype Analysis, AngioDynamics Correlation and AngioDynamics Performance. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.59) | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets | Return On Equity |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.